Therapeutic applications of transcription factor decoy oligonucleotides
Open Access
- 1 November 2000
- journal article
- review article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 106 (9) , 1071-1075
- https://doi.org/10.1172/jci11459
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Developing aptamers into therapeuticsJournal of Clinical Investigation, 2000
- Escort aptamers: a delivery service for diagnosis and therapyJournal of Clinical Investigation, 2000
- Activation of Nuclear Factor‐κB in C6 Rat Glioma Cells After Transfection with Glia Maturation FactorJournal of Neurochemistry, 2000
- A non-nucleotide–bridged DNA decoy inhibits renal epithelial nitric oxide synthase expressionKidney International, 2000
- A Pressure-Mediated Nonviral Method for Efficient Arterial Gene and Oligonucleotide TransferHuman Gene Therapy, 1999
- Selection and Characterization of an RNA Decoy for Transcription Factor NF-κBBiochemistry, 1999
- Etoposide and cisplatin induced apoptosis in activated RAW 264.7 macrophages is attenuated by cAMP-induced gene expressionOncogene, 1998
- Use of Phosphorothioate-Modified Oligodeoxynucleotides to Inhibit NF-κB Expression and Lymphocyte FunctionClinical Immunology and Immunopathology, 1998
- In vivo identification of a negative regulatory element in the mouse renin gene using direct gene transfer.Journal of Clinical Investigation, 1995
- Stranger in a strange land: The pathogenesis of saphenous vein graft stenosis with emphasis on structural and functional differences between veins and arteriesProgress in Cardiovascular Diseases, 1991